This study examines HER2 ISH-equivocal breast cancers to asses 2013/2014 American Society of Clinical Oncology and College of American Pathologists guidelines in determining HER2-positive or HER2-negative breast cancers and false-positive results.
https://ift.tt/2RFlLVE
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου